SCHEMBL7871869

SCHEMBL7871869

CCCCOc1cccc(OCCN(C)C(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.49
KDM4E B2RXH2 2/20 0.49
GPBAR1 Q8TDU6 2/20 0.47
CYSLTR2 Q9NS75 1/20 0.47
CYSLTR1 Q9Y271 1/20 0.47
CHRNB2 P17787 1/20 0.46
CHRNA4 P43681 1/20 0.46
CYP2D6 P10635 1/20 0.46
THRA P10827 1/20 0.45
THRB P10828 1/20 0.45
LTA4H P09960 1/20 0.45
PLA2G4B P0C869 1/20 0.44
ACACB O00763 1/20 0.43
ACACA Q13085 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CACNA1B Q00975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edronocaine SCHEMBL7612799 0.92 KDM4E (0.50) TSHRKDM4EGPBAR1CYSLTR1CHRNB2
Edronocaine SCHEMBL29388132 0.92 KDM4E (0.50) TSHRKDM4EGPBAR1CYSLTR1CHRNB2
SCHEMBL7872686 0.86 LTA4H (0.55) TSHRKDM4EGPBAR1CYSLTR2CYSLTR1
SCHEMBL7863707 0.83 TSHR (0.51) TSHRKDM4EGPBAR1CYSLTR2CYSLTR1
SCHEMBL10442255 0.82 CA12 (0.47) KDM4ECYP2D6LTA4HALDH1A1SMN1; SMN2
SCHEMBL15279073 0.81 TSHR (0.46) TSHRKDM4EGPBAR1CYSLTR2CYSLTR1
SCHEMBL7875705 0.81 TSHR (0.54) TSHRKDM4EGPBAR1CYSLTR2CYSLTR1
SCHEMBL4397448 0.81 TSHR (0.63) TSHRGPBAR1CYSLTR2CYSLTR1CYP2D6
SCHEMBL12744959 0.80 LTA4H (0.58) TSHRCHRNB2CHRNA4LTA4HALDH1A1
SCHEMBL7863714 0.79 TSHR (0.51) TSHRKDM4EGPBAR1CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310252-B1 AS TOPICAL ANAESTHETICS ASTRAZENECA AB (SE) 2001-10-30 US claimed
EP-1047412-A1 NEW USE OF LOCAL ANAESTHETICS AGAINST VASCULAR HEADACHES AstraZeneca AB (SE) 2000-11-02 EP claimed
WO-1999032103-A1 NEW USE OF LOCAL ANAESTHETICS AGAINST VASCULAR HEADACHES ASTRAZENECA AB (SE) 1999-07-01 WO claimed
EP-0858445-A1 NEW (3-ALKOXY-PHENOXY)-ETHYL]-DIALKYLAMINE DERIVATIVES AND THEIR USE AS LOCAL ANAESTHETICS Astra Aktiebolag (SE) 1998-08-19 EP claimed
WO-1997015548-A1 NEW [(3-ALKOXY-PHENOXY)-ETHYL]-DIALKYLAMINE DERIVATIVES AND THEIR USE AS LOCAL ANAESTHETICS ASTRA AKTIEBOLAG (SE) 1997-05-01 WO claimed
US-6310252-B1 AS TOPICAL ANAESTHETICS ASTRAZENECA AB (SE) 2001-10-30 US disclosed
EP-1047412-A1 NEW USE OF LOCAL ANAESTHETICS AGAINST VASCULAR HEADACHES AstraZeneca AB (SE) 2000-11-02 EP disclosed
WO-1999032103-A1 NEW USE OF LOCAL ANAESTHETICS AGAINST VASCULAR HEADACHES ASTRAZENECA AB (SE) 1999-07-01 WO disclosed
EP-0858445-A1 NEW (3-ALKOXY-PHENOXY)-ETHYL]-DIALKYLAMINE DERIVATIVES AND THEIR USE AS LOCAL ANAESTHETICS Astra Aktiebolag (SE) 1998-08-19 EP disclosed
WO-1997015548-A1 NEW [(3-ALKOXY-PHENOXY)-ETHYL]-DIALKYLAMINE DERIVATIVES AND THEIR USE AS LOCAL ANAESTHETICS ASTRA AKTIEBOLAG (SE) 1997-05-01 WO disclosed